Cheplapharm From Greifswald and Sanofi Before Billions Deal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
The Greifswald-based pharmaceutical company Cheplapharm announced a billion-dollar deal on Monday afternoon with the French pharmaceutical company Sanofi, which is one of the world's largest companies with 83,000 employees.
Greifswald/Paris – Greifswald-based pharmaceutical company Cheplapharm plans to increase its annual sales by around one billion euros with a deal with the French pharmaceutical giant Sanofi and to take over three production sites abroad. Cheplapharm is expected to acquire and market 20 medicines from Sanofi. In return, the French...
The French pharmaceutical company Sanofi acquires a quarter of Cheplapharm's shares. Greifswalder acquires important medicines and factories – and becomes the fifth largest German pharmaceutical company.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
